



Energy balance in cystic fibrosis when stable and
during a respiratory exacerbation
Citation for published version (APA):
McCloskey, M., Redmond, A. O., McCabe, C., Pyper, S., Westerterp, K. R., & Elborn, S. J. (2004). Energy
balance in cystic fibrosis when stable and during a respiratory exacerbation. Clinical Nutrition, 23(6),
1405-1412. https://doi.org/10.1016/j.clnu.2004.06.010





Publisher's PDF, also known as Version of record
Document license:
Taverne
Please check the document version of this publication:
• A submitted manuscript is the version of the article upon submission and before peer-review. There can
be important differences between the submitted version and the official published version of record.
People interested in the research are advised to contact the author for the final version of the publication,
or visit the DOI to the publisher's website.
• The final author version and the galley proof are versions of the publication after peer review.




Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these
rights.
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
• You may not further distribute the material or use it for any profit-making activity or commercial gain
• You may freely distribute the URL identifying the publication in the public portal.
If the publication is distributed under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license above,
please follow below link for the End User Agreement:
www.umlib.nl/taverne-license
Take down policy
If you believe that this document breaches copyright please contact us at:
repository@maastrichtuniversity.nl
providing details and we will investigate your claim.
Download date: 03 Nov. 2021







Energy balance in cystic fibrosis when stable and
during a respiratory exacerbation
Margaret Mc Closkeya,, Aileen O.B. Redmonda, Christine Mc Cabea,
Siobhan Pypera, Klass R. Westerterpb, Stuart J. ElbornaaAdult and Paediatric Cystic Fibrosis Units, Belfast City Hospital and Royal Belfast Hospital for Sick
Children, Belfast, Northern Ireland, UK
bDepartment of Human Biology, University of Maastricht, Holland
Received 17 February 2003; accepted 12 June 2004S
ake;
enditure
ee front matter r 200
lnu.2004.06.010
ng author. Tel.: +44-28
ess: mccloskeymargareSummary Background & aims: Undernutrition is common in young adult patients
with cystic fibrosis (CF) and implies an imbalance between energy intake and total
energy expenditure (TEE). The aim of this study was to measure energy intake and
TEE expenditure in a group of patients when they were clinically stable at home and
during an exacerbation of respiratory symptoms when they were in hospital receiving
intravenous antibiotics.
Methods: Eleven patients aged between 15 and 40 years with moderate
respiratory disease, mean FEV1 51.4% predicted took part. An exacerbation was
defined as415% decrease in FEV1, an increase in sputum production and a decision
to treat in hospital with intravenous antibiotics. Resting energy expenditure (REE)
was measured using indirect calorimetry and energy intake by 3 day food diaries. TEE
expenditure was measured using 24 h heart rate and doubly isotopically labelled
water.
Results: REE was higher at the beginning of an exacerbation than the end,
Po0.05. There was no significant difference in TEE during the stable period
compared to the exacerbation 10.53(2.39) MJ/day compared to 8.77(1.59) MJ/day
using doubly isotopically labelled water. There was no difference in energy intake
during the exacerbation compared to the stable period, 11.19(2.31) MJ/day
compared to11.77(2.30) MJ/day.
Conclusions: There was no difference in TEE and energy intake when patients
were unwell in hospital compared to when they were stable at home despite an
increase in REE.
r 2004 Elsevier Ltd. All rights reserved.4 Elsevier Ltd. All rights reserved.
-90329241x3119; fax: +44-28-90263546
t@hotmail.com (M. Mc Closkey).
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Reduced body weight is a common problem within
the cystic fibrosis (CF) population and is an adverse
prognostic indicator.1–4 This is due to a disturbance
of energy balance resulting from either decreased
energy intake (EI), increased total energy expendi-
ture (TEE) or a combination of both.5 The contribu-
tion of either decreased EI or increased TEE has not
been fully assessed in the CF population.
Many studies assessing energy balance in other
chronic diseases including lung carcinoma and
Crohn’s disease have used resting energy expendi-
ture (REE) as an estimate of TEE. However an
increase in REE, which accounts for about 80% of
TEE, which has been demonstrated in these
conditions does not necessarily imply an increase
in TEE therefore the energy balance equation is
incomplete.6,7 There has however been a recent
study assessing the full energy balance equation in
patients with human immunodeficency virus (HIV)
infection, this study found that weight loss in
patients with HIV infection was due to a decrease in
EI and that TEE remained unchanged or decreased
despite an increase in REE.8
Some studies have noted an increase in REE in
patients with CF associated with a respiratory
exacerbation which subsequently reduces signifi-
cantly after a course of intravenous antibiotics.9
This increase in REE has been associated with a
change in intermediary metabolism, such as an
increase in catecholamine levels, increased lipoly-
sis and increased proteolysis. Some of these effects
have been shown to be mediated by pro-inflamma-
tory cytokines particularly tumour necrosis factor
alpha (TNFa).10 TNFa has also been shown to have
an anorectic effect resulting in a decreased energy
intake.11
The aim of the present study was to assess the
full energy balance equation in patients with CF by
measuring EI, REE and TEE in adolescent and adult
patients with CF when they were stable and during
the treatment of an exacerbation of respiratory
symptoms.Materials and methods
Eleven patients with CF mean age 23 years (range
15–40 years ) and moderately severe respiratory
disease, FEV1 30–70% predicted were recruited.
Patients were studied when they were clinically
stable and during an exacerbation of respiratory
symptoms. A respiratory exacerbation was deter-
mined as more than 15% decrease in FEV1 from anindividual’s usual level, an increase in sputum
production, patient perception of a worsening of
symptoms and a physician decision to treat with 2
weeks of intravenous antibiotics.
Each study period was 2 weeks. When the
patients had an exacerbation of symptoms they
were in hospital for at least the first 10 days of
treatment. The only difference in medication
between the two study periods was the intravenous
antibiotic therapy during the exacerbation. All
patients were chronically colonised with Pseudo-
monas aeruginosa (P. aeruginosa)and some were
colonised with Burkholderia cepacia (B. cepacia) in
addition to the P. aeruginosa.Measurement of resting energy expenditure
Subjects attended the study room between 8.00
and 9.30 am, having fasted from 10.00 pm the
previous night. Subjects were driven straight to
the study room from their own home or from
hospital. Patients had omitted their usual am
medication on the morning of the study. All
subjects rested on the bed in the study room which
was inclined at 451 to the horizontal for a period of
twenty minutes to acclimatise. They then had gas
exchange measurements taken for 20min at 15 s
intervals. A face mask was used to collect expired
air as previous studies had shown no difference in
REE measurements using a face mask or a mouth
piece.12 Coughing did not prove to be a problem
during the measurements. All subjects attended
the study room on day one and between day 12 and
day 14 to have REE measured. They all had been
familiarised with the equipment on a previous visit
before any of the studies commenced. REE was
calculated from O 2 consumption and CO2 produc-
tion using the modified Weir equation.13Measurement of total energy expenditure
TEE was assessed using doubly isotopically labelled
water (DLW) and 24 h heart rate (24 h HR) metho-
dology.
Doubly isotopically labelled water: DLW is the
gold standard field technique for the measurement
of TEE, the main limiting factor in its use is the cost
of the isotopes. The technique is based on the
principle that 2H labels the body water pool and O18
labels both the water and bicarbonate pools so that
CO2 production can be estimated from the differ-
ence in elimination of the two isotopes.14–16 In
these studies the Masstricht protocol for measure-
ment of EE using DLW wa s followed.17 This involves
a six point protocol allowing comparison of TEE
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Energy balance in cystic fibrosis 1407within the first and second week of a fourteen day
observation period comparison of TEE within the
first and second week of a fourteen day observation
period to check for sampling errors. The protocol in
these studies was as follows:1 Patients were weighed before entering the study
and body water was estimated from age, sex and
weight specific formulae.182 Weighted isotope doses were ordered from the
University of Limburg, Masstricht according to
estimated body water of the subjects.3 On day zero of the study period subjects passed a
pre-dose urine sample at 9 pm, they then drank
the weighted dose of isotope, which contained
0.05 g/kg body water of 2H2O and 0.1 g/kg body
water of H2O
18, the volume of water being
between 80 and 120ml. Subjects drank the water
straight from the bottle and then rinsed the
bottle with 50mls of tap water and drank this
also, this was to ensure all the isotopes were
consumed.4 The next morning (day 1) patients collected a
sample from their second voiding and then
collected a second sample on the evening of
day 1, noting the time at which the sample was
collected.5 Samples were then collected on day 8 morning
and evening and day 15 morning and evening.
Body composition was measured from the morn-
ing voiding of day 1 after a 10 h equilibration
period. Samples were frozen at 20 1C until
transfer to Masstricht for analysis.
Twenty-four hour heart rate methodology: The
physiological basis of this method is related to the
fact that heart rate (HR) increases with oxygen
consumption in a linear fashion during physical
activity.19–22 Patients were studied in the morning
10min after having REE measured. Patients under-
went calibration on day 1 and day 12 of the 2 week
study period. Patients sat for 6min, stood for 6min,
walked on a treadmill for 6min at a speed of
2.7 km/hour and gradient of 5% and if able at a
speed of 4.0 km/hour and a gradient of 10% for
6min. Patients who were in hospital were generally
unable to perform the second stage of this exercise
program, therefore a modified program was used:
6minutes at a speed of 2 km/hr and 0 gradient, and
6minutes at a speed of 2.7 km/h and 0 gradient. A
preliminary 3min equilibration period was allowed
at each stage followed by a 3min sampling period.
The calibration point for each activity was taken as
the mean of the 3min sampling period for HR and
VO2. Expired gas was collected via a face mas-
k(Hans Rudolph Inc, Kansas City) to the Quintonequipment. An individual heart rate /O2 consump-
tion graph was drawn manually after each calibra-
tion.
Patients then put on a heart rate monitor (Polar
Sports Tester, Kempele, Finland) and wore this until
going to bed the same night, monitors were
removed at night as sleep energy expenditure was
estimated as REE.
Fat free mass (FFM) was calculated from the first
early morning sample as previously described.17
TEE was calculated from 24 hour HR methodology
by assessing FLEX heart rate, which is the mean of
the highest resting heart rate and lowest heart rate
during exercise during the calibration procedures
and drawing individual HR/O2 consumption curves
as described previously.20,21 TEE by the DLW
method was calculated from the different elimina-
tion rates of deuterium and oxygen 18 as de-
scribed.15,17
Assessment of dietary intake
Dietary intake was assessed by 3 day food diaries
recorded on day one to three of each study
period.23–26 Each patient collaborated with a
dietitian specialising in CF. Dietary records were
converted to EI by COMPEAT (version four).
Statistical analysis
Comparison of data when patients are stable and
during an exacerbation was by paired t-tests.
Correlation between variables was by linear regres-
sion. Comparison between 24 h HR and DLW
methodology was assessed by the method of Bland
and Altman.27 TEE measurements and EI measure-
ments were expressed in MJ/day.
Ethical approval
This study was approved by the ethical committee
of Queens University of Belfast and all subjects
gave written informed consent to participating in
the study.Results
Six female and five male patients with CF took part
in this study over an 18 month period. All patients
participated in both parts of the study, completing
2 weeks of energy balance measurements when
they were stable and when they were in hospital
receiving intravenous antibiotic therapy. Four
patients completed the exacerbation part of the
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study first. There was at least three months
between the two study periods, the longest interval
was seven months, mean interval was 4.2(1.2)
months. DLW data were incomplete in 3 patients.
Patient numbers 2 and 7 did not take DLW during a
respiratory exacerbation as supplies were not
available at the time they became acutely unwell.
Patient number 6 broke the bottle of DLW during
the exacerbation but did not reveal this until he
had completed the study. Six patients were
colonised with P. aeruginosa alone and five patients
were colonised with B. cepacia and P. aeruginosa.
All patients received 2 weeks of intravenous anti-
pseudomonal antibiotics during the exacerbation
period. Those patients who were colonised with B.
cepacia were treated with antibiotics with in vitro
sensitivities to the organism, no patients in the
study were colonised with multi-resistant B. cepa-
cia on in vitro testing at the time of participating in
the study.
The mean weight of patients during the stable
period was 50.2(9.6) kg and 49.9(10.1) kg at the
beginning of the exacerbation period, this differ-
ence was not significant. At the end of the
exacerbation mean weight was 50.4(10.3) kg. Six
patients increased their body weight during the
exacerbation and four maintained their body
weight, one patient lost weight during the exacer-
bation. Mean FEV1 during the stable period was
51(11)% predicted. This was significantly higher
than at the beginning of the exacerbation period
37(9)% predicted (Po0.05). By the end of the 2
weeks of intravenous antibiotics FEV1 was similar to
during the period of clinical stability 49(11)%
predicted (Table 1).
REE was higher at the beginning of an exacerba-
tion compared to the end 8.3 (0.9) MJ/day com-
pared to 7.1(1.2) MJ/day, (Po0.05) at the end of
the intravenous antibiotics. There was no differ-
ence between REE during the stable period
7.3(0.9) MJ/day and the end of the exacerbation.
There was no significant difference between TEE
during the period of clinical stability and during the
exacerbation, however there was a trend for TEE to
be lower during the exacerbation period compared
to the stable period using either 24 h HR or DLW
methodologies (Table 2). TEE measurements by
DLW and 24 h HR methodologies during the stable
period and during the exacerbation were similar,
the mean difference between the two methods
being 14(11)% in patients when they were stable
and 13(18)% during the exacerbation. There was no
correlation between TEE and FFM or FEV1.
Resting heart rate was significantly higher at the
start of an exacerbation 85 (5) beats per min anddecreased by the end of the exacerbation 81 (6)
beats/min (Po0.05).
During the period of clinical stability heart rate
was 79 (7) beats/min. FLEX heart rate was higher
but not significantly so at the beginning of an
exacerbation 103 (8) beats/min compared to the
end 101 (7) beats/min. FLEX heart rate also tended
to be higher at the end of the exacerbation
compared to the period of clinical stability 99 (7)
beats/min, this was not statistically significant.
Physical activity levels (PAL) were significantly
higher when patients were stable 1.3(0.1) com-
pared to the beginning of an exacerbation
1.1(0.004), P=0.001. There was no significant
difference in PAL at the beginning of an exacerba-
tion compared to the end 1.2(0.2) (Table 3).
There was no significant difference between EI
during the period of clinical stability, 11.2 (2.3) MJ/
day and during the exacerbation, 11.8 (2.3) MJ/day
(Table 4). When patients were divided into those
who increased in weight during the treatment of an
exacerbation and those who remained the same
weight or lost weight there was a difference
between TEE and EI during the two periods. Those
patients who increased weight had an increase in
their EI during the exacerbation. There was good
correlation between TEE and EI during the stable
period using 24 h HR methodology, r2=0.6, P=0.03.
Correlation between TEE and EI using DLW metho-
dology was r2=0.6, P=0.08 which is not significant.
There was no correlation between TEE and EI
during the exacerbation periods using both meth-
odologies. There was no correlation between EI and
FFM.Discussion
This study indicates that during an exacerbation of
respiratory symptoms in patients with moderately
severe CF, TEE is not increased despite an increase
in REE compared to a period of clinical stability.
This study found a similar pattern to other
published studies measuring REE during an exacer-
bation of respiratory symptoms, that is that REE is
increased at the beginning of an exacerbation and
decreases to levels seen when patients are stable
by the end of 2 weeks of intravenous antibiotics.9,28
Despite this increase in REE there is not a
corresponding increase in TEE. Physical activity
levels were decreased at the beginning of treat-
ment of an exacerbation compared to when
patients were stable.
This is similar to published data in patients with


































































































































































































































































































































































































































Energy balance in cystic fibrosis 1409strated an increase in REE in these patients but TEE
was similar to control populations.8 A number of
similar studies in patients with chronic obstructive
pulmonary disease (COPD) have given conflicting
results. Baarends et al. demonstrated no difference
in TEE in patients with COPD who had an increase in
REE and those who had a normal REE.29 Interest-
ingly Baarends, in a further study demonstrated
that TEE was increased in patients with COPD
relative to a control population whereas Hugli
found no difference in TEE in patients and
controls.30,31 The patients in Baarends study were
undergoing a pulmonary rehabilitation program so
differing physical activity levels between the study
groups could explain the conflicting results as well
as differing techniques as Hugli used a 24 h
calorimeter in his study.
All of the patients in this study had moderately
severe lung disease, mean FEV1 54% predicted and
the data on TEE in this sub population cannot be
extrapolated to those more severely ill patients
with an FEV1o30% predicted or indeed those
patients who are mildly affected with an
FEV1470% predicted as it is possible that deterior-
ating pulmonary function is associated with a more
marked restriction on physical activity which may
result in different TEE measurements.
We have previously assessed the repeatability
and reproducibility of 24 h HR methodology in
patients with CF compared to the DLW method
and found the technique to have good group
repeatibility and reproducibility.32 We also found
that 24 h HR consistently underestimated TEE in
patients and in a control group compared to DLW,
other workers have noted this as well within normal
populations.14,16,32 The results of this study are in
keeping with these previous findings and demon-
strate that the 24 h HR technique is valid for
measuring TEE in patients during an exacerbation
of respiratory symptoms as well as when they are
stable.
Body weight increased in those patients who
increased their EI whilst in hospital. Those patients
who did not increase their EI did not have a
corresponding increase in body weight and because
TEE did not alter in the patients it is the change in
EI which resulted in the increase in weight.
The authors are aware that the numbers
recruited in the present study were small which
limits the degree to which the data can be
interpreted and this is a valid criticism of the
study. There are two main reasons for the small
numbers, the major one being that the study was
very intensive and time consuming for the patients.
It involved a huge amount of cooperation on their
part. Fourteen patients completed both parts of
ARTICLE IN PRESS
Table 2 Total energy expenditure in patients when they are stable and during an exacerbation of respiratory
symptoms using 24 h HR and DLW methods.











1 8.7 7.5 7.4 12.0 10.2
2 10.4 9.5 9.0 10.3 N/A
3 8.5 8.6 7.1 8.0 7.1
4 7.7 7.9 9.0 8.6 9.3
5 10.0 7.3 7.8 11.1 7.7
6 10.5 10.3 10.7 N/A 12.1
7 7.6 8.3 9.4 9.2 N/A
8 10.3 11.7 10.9 13.4 8.5
9 8.2 7.6 6.6 9.3 7.3
10 6.1 6.5 5.3 8.2 8.0
11 11.7 9.2 8.9 15.2 8.8
Mean 9.1 8.6 8.4 10.5 8.8
SD 1.7 1.5 1.7 2.4 1.6
Table 3 Physical acticity levels in patients when
stable and during an exacerbation.




1 1.2 1.1 1.1
2 1.4 1.1 1.1
3 1.2 1.1 1.2
4 1.5 1.2 1.6
5 1.3 1.1 1.1
6 1.5 1.2 1.5
7 1.2 1.1 1.3
8 1.1 1.2 1.2
9 1.4 1.1 1.1
10 1.2 1.1 1.1
11 1.5 1.1 1.1
Mean 1.3* 1.1* 1.2
SD 0.1 0.004 0.2
*Statistically significant difference Po0:001.
M. Mc Closkey et al.1410the study but three had to be excluded from the
analysis because when the principal investigator
tried to collect various samples or pieces of
equipment the data was unreadable or false. Five
patients completed the first half of the study but
refused to complete the second 2-week study
period. This reflects the huge amount of work
those who did participate actually performed and
the authors feel confident that despite the small
numbers, the data is very accurate as the nature of
the study selected out patients who were very
diligent and precise in their habits. The second
reason for the small numbers was the high financial
cost in the purchasing and analysing of the DLW.A recent study by Bines et al. found that REE and
TEE in newborn infants with CF is not different from
a control population but it is possible that this
pattern of energy expenditure changes as infants
grow.33 The study by Naon et al. assessed
changes in REE and EI in prepubertal children
during a respiratory exacerbation and found the
increase in REE during an exacerbation to be
higher than the increase in EI concluding that an
increase in energy expenditure was the cause of
weight loss and not decreased EI.34 An increase
in EI in prepubertal children during a respiratory
exacerbation has been reported but energy ex-
penditure was not measured at the time.35 A
decrease in EI in patients with CF when they are
unwell has been reported but this did not occur in
our population group. It is possible that in our
patient group there was a decrease in EI the few
days prior to hospital admission when they were
unwell at home and when they were actually
admitted to hospital and commenced treatment
and were seen by a CF dietitian who was strongly
encouraging food intake, the usual anorexia was
overcome. This suggests that in hospital treatment
of infective exacerbations of symptoms in adoles-
cent and adult patients with CF may be beneficial
nutritionally by maintaining EI. Patients were
strongly encouraged to eat when in hospital and it
would be informative to measure EI in young
adolescent and adult patients similar to this group
when treated for a respiratory exacerbation with
‘‘at home’’ antibiotics.
The lack of correlation between EI and TEE
during the exacerbation may be related to these
external influences on eating pattern and it would
ARTICLE IN PRESS
Table 4 Energy balance according to change in weight during the exacerbation period.
Stable Exacerbation
Patient Weight change (kg) TEE TEE EI TEE TEE start TEE end EI
DLW (MJ) HR (MJ) (MJ) DLW (MJ) HR (MJ) HR (MJ) (MJ)
Patients who had an increase in weight during the exacerbation period
1 0.2 12.0 8.7 10.5 10.2 7.5 7.4 14.7
2 2.4 10.3 10.4 12.1 9.5 9.0 13.0
5 1.4 11.1 10.0 12.7 7.7 7.7 7.8 14.0
6 0.2 10.5 10.1 12.1 10.3 10.7 14.6
8 0.6 13.4 10.3 11.1 8.5 11.6 10.9 7.6
9 0.5 9.4 8.2 9.5 7.3 7.6 6.6 10.8
Mean 11.2 9.7 11.2 9.2 9.0 8.7 12.3
SD 1.6 9.8 1.4 2.0 1.7 1.8 2.8
Patients who did not change weight during the exacerbation period
3 0.0 8.0 8.5 12.4 7.1 8.6 7.1 12.8
4 0.0 8.6 7.7 9.5 9.3 7.9 9.0 10.3
7 0.2 9.2 7.6 7.2 8.3 9.4 8.7
10 0.0 8.2 6.1 11.0 8.0 6.5 5.3 12.5
11 0.0 15.2 11.7 16.0 8.8 9.2 8.9 11.3
Mean 9.8 8.3 11.2 8.2 8.1 7.9 11.1
SD 3.0 2.1 3.3 1.0 1.0 1.7 1.7
Energy balance in cystic fibrosis 1411be helpful to know whether when patients are
treated at home there is a more direct correlation
between EI and TEE. Equally important is the issue
of EI in patients with more severe respiratory
disease as this may not be the same as those
patients with moderate disease.
Reilly et al. measured energy balance in children
with CF when they were stable and during an
exacerbation.36 They did not find an increase in REE
during an exacerbation although half of the 14
patients in the study had excellent lung function
with FEV1480% predicted. It was also noted that
TEE was the same in children when they were
stable compared to during an exacerbation
although there did seem to be a trend for TEE to
be actually decreased during an exacerbation, this
is similar to our findings in young adult patients.
This may be related to the increased energy
required for physical activity in CF as noted in a
recent study.37 We had previously shown that TEE in
a stable group of patients was not increased
relative to a control population despite an increase
in REE and this seem to occur because patients had
a decrease in physical activity levels.30 It is possible
that by decreasing physical activity levels even
further during an exacerbation an increase in TEE is
avoided.
In summary this study shows that in young adult
patients with CF with moderately severe respira-
tory disease TEE is maintained or decreased during
an exacerbation of respiratory symptoms despite anincrease in REE when they are treated in hospital
but EI is maintained.Acknowledgements
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